Harvard Apparatus Regenerative Technology (NSDQ:HART) said today it is rebranding as Biostage, Inc. and shifting its Nasdaq symbol to “BSTG”, effective April 1. The company said the brand shift “reflects the company’s broad commitment and expertise in pioneering the development of bioengineered organ implants for the esophagus, bronchus and trachea.” “The Biostage name change reflects the evolution of […]
Harvard Apparatus Regenerative Technology (HART)
Jim McGorry, CEO of Harvard Apparatus Regenerative Technology (NSDQ:HART), said he’s ready to right the ship at HART by expanding its regenerative trachea tech into both the bronchus and esophagus. McGorry has been the CEO of HART for 4 months, and told the Boston Business Journal he’s preparing to turn the company’s stock slide around. The reins were […]
Considered a leader in diabetes research, Zisser will be involved with a variety of clinical research projects and serve as a medical liaison between Insulet and government leaders, the FDA, and healthcare organizations, Bedford, Mass.-based Insulet said.
Marlborough, Mass.-based medical device company Boston Scientific is 1 of the Emerald Isle’s largest employers, with a 4,500-employee workforce there.